BIT's 10th Annual World Cancer Congress -2017 (WCC-2017) will be held on 19-21, May 2017 in Barcelona, Spain.
WCC-2017 provides a unique and ideal opportunity for a broad spectrum of researchers, clinicians and other health professionals to meet, discuss, share, learn and connect in order to find solutions to reduce the impact of cancer in the world. With the participation of outstanding international experts, we hope productive discussions would stimulate new creative ideas to translate new discoveries into better diagnosis and treatment of cancer patients.
WCC-2017 enables presenters and delegates to enjoy the state of the art oral and poster presentations covering the in-depth findings into the cause and processes of the disease and recent advances in clinical practice, from prevention to diagnosis, treatment and care.
We hope your participation would contribute to your professional development and relationships. Wish you enjoy the conference.
|Dr. Kenneth Olden, Director, EPA’s National Center for Environmental Assessment, USA||Dr. Steven T. Rosen, Provost & Chief Scientific Officer, City of Hope Comprehensive Cancer Center, USA||Dr. Karol Sikora, Chief Medical Officer & Dean, Proton Partners International & University of Buckingham Medical School, UK|
|Dr. Bennard van Ravenzwaay, Senior Vice President, BASF SE, Germany||Dr. Konstantinos Konstantopoulos, Professor & Chair, The Johns Hopkins University, USA||Dr. Alvaro Macieira-Coelho, Director, French National Institute of Health, France|
|Dr. Miquel Pons, Full Professor & Group Leader, Biomolecular NMR Group; Faculty of Chemistry, University of Barcelona, Spain||Dr. Thierry Virolle, Director of Research, INSERM, France||Dr. Doron Melamed, Professor, Department of Immunology, Faculty of Medicine, Technion, Israel|
|Dr. Dominique Belpomme, Professor, University of Paris; Director, the European Cancer and Environment Research Institute (ECERI), France||Dr. Juan Sanabria, Professor, Vice-chair & Scientific Director, Comprehensive Cancer Center, USA||Dr. Michel Janicot, Founder & CEO, JMi ONConsulting, Belgium|
|Dr. Gerd Birkenmeier, Professor, University of Leipzig, Germany||Dr. Fabio Mammano, Professor & Director, CNR Institute of Cell Biology and Neurobiology, Italy||Dr. Aikaterini Kontrogianni-Konstantopoulos, Professor, University of Maryland School of Medicine, USA|
|Dr. Peter L. Elkin, Professor & Director, Department of Biomedical Informatics, University at Buffalo, USA||Dr. Andrei P. Kozlov, Professor, Director of Biomedical Center & Chief, Lab of Molecular Virology and Oncology, Peter the Great Polytechnic University, Russia||Mr. Steven Eror, President & CEO, ProLungdx, USA|
|Dr. Paul S. Rennie, Professor & Director, Laboratory Research, The Vancouver Prostate Centre & University of British Columbia, Canada||Dr. Karim Malik, Reader & Associate Professor, University of Bristol, UK||Dr. Giulio Tarro, President, Foundation de Beaumont Bonelli for Cancer Research, Italy|
|Dr. Nira Ben-Jonathan, Professor, University of Cincinnati, USA||Dr. Jan Groen, CEO, MDxHealth, Belgium||Dr. Steven Warner, VP, Discovery and Development, Tolero Pharmaceuticals Inc., USA|
|Dr. Mohamed Aziz, Senior Surgical Pathologist, USA; Professor of Pathology, American University of the Caribbean Medical School, St. Maarten, Dutch Antilles||Dr. Masahiro Tsubaki, Vice President, Yuai Memorial Hospital, Japan||Dr. Brigitte Guerin, Full Professor, Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Canada|
|Dr. Colleen Huber, President & Medical Director, Naturopathic Cancer Society & Nature Works Best Cancer Clinic, USA||Dr. Dimcho Bachvarov, Professor, Laval University, Canada||Dr. Nathalie Rivard, Full Professor & Director, Universite de Sherbrooke, Canada|
|Dr. Eva Estebanez-Perpina, Associate Professor & Serra Hunter Fellow, Biochemistry and Molecular Biology, Institute of Biomedicine, University of Barcelona (IBUB), Spain|
As part of the 2017 World Cancer Congress, an exhibition space will provide a unique opportunity for exhibitors to showcase their products and services to participants with interests in all areas of cancer. Developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent and repeated opportunities for delegates to visit the exhibits.
• The exhibition will be visited by participants of the conference it means by your authentic target group from China and other countries.
• The exhibitors have the opportunity to present their exhibits more detailed, and have the opportunity for longer discussion with inquiring visitors – in most cases specialists – than during session discussions.
BIT Group Global Ltd.
Dr. Thomas Tursz
Professor & Honorary Director
Institut Gustave Roussy, France
Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2014-2015 BIT Congress Inc.